| 08-Dec-25 |
Buy |
Matthew Moulding |
32.30p | 209,086,400 |
£67,534,910.09 |
| 24-Nov-25 |
Transfer To |
Matthew Moulding |
44.00p | 181,818,176 |
£79,999,997.01 |
| 24-Nov-25 |
Transfer To |
Matthew Moulding |
44.00p | 181,818,176 |
£79,999,997.01 |
| 08-Dec-25 |
Buy |
Matthew Moulding |
32.30p | 209,086,400 |
£67,534,910.09 |
| Matthew Moulding |
390,904,588 |
£179,737,930 |
| Charles Allen |
2,942,000 |
£1,352,732 |
| Damian Sanders |
487,487 |
£224,146 |
| Susan Jane Farr |
145,243 |
£66,783 |
| Helen Jones |
134,084 |
£61,652 |
| Gillian Kent |
53,500 |
£24,599 |
| Dean Moore |
53,143 |
£24,435 |
| Frasers Group plc |
172,357,765 |
£79,250,100 |
| Sofina Capital S.A |
127,494,951 |
£58,622,178 |
| Matthew Moulding |
98,596,539 |
£45,334,689 |
| Balderton Capital IV, L.P |
96,947,470 |
£44,576,447 |
| Qatar Investment Authority |
95,148,959 |
£43,749,491 |
| Merian Global Investors |
86,972,130 |
£39,989,785 |
| SB Northstar LP |
80,621,797 |
£37,069,902 |
| Jupiter Fund Management plc |
62,034,208 |
£28,523,329 |
| T. Rowe Price |
60,908,595 |
£28,005,772 |
| 16:35 |
655,585 @ 45.98p |
| 16:35 |
544 @ 45.98p |
| 16:35 |
804 @ 45.98p |
| 16:35 |
1,424 @ 45.98p |
| 16:35 |
1,156 @ 45.98p |
| CEO |
Matthew Moulding |
| CFO |
Damian Sanders |
| Chair |
Charles Allen |
Top of Page
You are here:
research